A cohort of 253 isolated LR resections from 3211 primary STS resections enabled evaluation of post-recurrence prognosticators with median 5.3-year follow-up and 83 disease-specific deaths. Higher LR ...
A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions. STS is a rare cancer that originates as an abnormal growth ...
Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in ...
Morning Overview on MSN
Triple pre-surgery combo therapy may boost immunity in sarcoma
A triple-drug regimen combining two immunotherapy agents with radiation before surgery appears to activate immune defenses ...
Fragmented care - receiving medical treatment at more than one facility - has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as ...
Twenty-five patients were recruited in the study (14 male and 11 female patients). The median number of previous lines was 2 (2-4) with 76% exposed to pazopanib. The 3-month PFR was 56% with a median ...
Fragmented care — receiving medical treatment at more than one facility — has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as ...
A randomized phase 2 maintenance strategy with cabozantinib 60 mg daily for up to 2 years failed to improve 4-month PFS ...
COLUMBUS, Ohio – Pancreatic cancer blood tests, genetic predictors of breast cancer survival and sarcoma treatment response prediction tools are among the research topics being presented by scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results